Sljedeći

Auto Play

Advanced or Recurrent Endometrial Cancer Clinical Trial

0 Pogledi • 07/09/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play